For most patients, an ERCP — endoscopic retrograde cholangiopancreatography — is a same-day outpatient procedure. The patient is sedated, the gastroenterologist passes a duodenoscope to the bile and pancreatic duct openings, a problem is diagnosed or treated, and the patient goes home that afternoon. For a small but documented subset of patients, the story instead ends in the intensive care unit. Within hours to days of the procedure, the patient develops fever, low blood pressure, confusion, and the cascade of organ failure that defines sepsis. This guide explains what is happening, why duodenoscopes are uniquely positioned to trigger it, and what survivors and families should be doing.
What Sepsis Is, in Plain English
Sepsis is the body’s overwhelming response to an infection somewhere in the body. The infection itself can be anywhere — a urinary tract infection, pneumonia, an abdominal abscess, a contaminated catheter line. When the body’s immune response to that infection turns chaotic, the resulting condition — sepsis — damages organs far away from the original infection site. Blood pressure drops. The kidneys stop working. The lungs fill with fluid. The clotting system fails. Without urgent and aggressive treatment, sepsis progresses to septic shock and death.
Sepsis is treatable when caught early. The Centers for Disease Control and Prevention estimates approximately 1.7 million U.S. adults develop sepsis each year, and roughly 350,000 die. Sepsis causes more annual U.S. deaths than breast cancer, prostate cancer, and AIDS combined. Survival depends heavily on how quickly the underlying infection is identified and treated.
Why the Duodenoscope Is Uniquely High-Risk
A duodenoscope is a specialized flexible endoscope used during ERCP procedures. It travels from the mouth, through the esophagus and stomach, and into the duodenum — the first section of the small intestine. From there, the gastroenterologist passes instruments through the scope’s working channel to access the openings of the bile duct and pancreatic duct.
Two structural features make duodenoscopes uniquely high-risk for transmitting infection:
- The elevator mechanism. At the distal tip of the scope, a small hinged elevator deflects the instrument up or down. The elevator’s crevices, joints, and recessed surfaces are notoriously difficult to clean. Bacteria that lodge there can survive the standard reprocessing cycle. The U.S. FDA has documented this design vulnerability since at least 2015. Our scope model identification guide walks through which Olympus models carry which version of this design.
- The procedure target. ERCP works in territory that is normally sterile — the bile and pancreatic ducts. The duodenum itself is not sterile, but the bile and pancreatic ducts are. Bacteria carried on a contaminated scope are introduced directly into sterile territory, where the body has no resident flora to compete with them.
The result: ERCP is the highest-risk endoscopic procedure for post-procedure infection. Even with a well-cleaned scope, the procedure itself can introduce small amounts of bacteria into the biliary tree. With a contaminated scope, the bacterial load is multiplied.
The Typical Timeline From Procedure to Sepsis
Post-ERCP sepsis usually follows one of two timelines.
The fast track: hours to a few days
In some cases, sepsis develops within 6 to 72 hours of the procedure. The patient may go home from the procedure feeling normal or mildly unwell. By the next morning, fever begins. By the second day, the fever is high and accompanied by shaking chills, abdominal pain, nausea, or confusion. The patient or family returns to the emergency department. If sepsis is recognized and treated promptly, outcomes can still be good. If it is missed at triage or treated as a generic post-procedure complaint, outcomes worsen rapidly.
The slow track: days to weeks
In other cases, bacteria introduced during the procedure establish a smoldering infection that escalates over 5 to 30 days. The patient may be discharged after the procedure and feel reasonably well at first. Over the following week or two, a low-grade fever appears, vague abdominal discomfort sets in, and the patient feels increasingly unwell without an obvious explanation. By the time the diagnosis is made — often when blood cultures are drawn at a return ED visit — the infection has spread, and sepsis is in motion.
Our scope infection symptom timeline guide walks through these patterns in more detail and lists the warning signs that should prompt a return to the ED.
The Treatment Standard: The Surviving Sepsis Campaign Hour-1 Bundle
The clinical standard of care for sepsis — in any U.S. emergency department or hospital — is the Surviving Sepsis Campaign Hour-1 Bundle. The bundle is an internationally endorsed set of five actions that should be initiated within an hour of recognizing sepsis:
- Measure lactate. Elevated lactate is a marker of tissue hypoperfusion and a key trigger for escalation of care.
- Obtain blood cultures before starting antibiotics. Identifying the specific bacterium guides antibiotic selection and, in scope cases, can be central evidence of the infection source.
- Administer broad-spectrum antibiotics. These should be selected to cover the likely pathogens based on the suspected source (gut and biliary flora for post-ERCP cases) and adjusted once cultures return.
- Begin rapid intravenous fluid resuscitation. 30 mL per kilogram of crystalloid is the starting volume for patients with septic shock or significantly elevated lactate.
- Start vasopressors if blood pressure remains low after fluids. Norepinephrine is typically first-line.
The Centers for Medicare & Medicaid Services has adopted a version of this bundle as the SEP-1 quality measure for hospitals. When sepsis is missed, mis-triaged, or treated slowly, the deviation from this standard becomes the focus of any subsequent legal case.
What Survivors and Families Should Document
If you or a family member developed sepsis after an endoscopy procedure and you are considering whether to talk to a lawyer, the following are worth preserving while the records are still fresh and complete:
- The procedure report. The endoscopist’s dictated note from the day of the ERCP. It will typically identify the indication, the scope model, the procedure findings, and any complications noted at the time. The how to identify the scope guide explains what to look for in the report.
- The procedure consent form. What you were told about infection risk before signing.
- The discharge instructions. What you were told to watch for after the procedure.
- The return-visit records. The ED note when you came back, the triage time, the lactate and culture results, the time antibiotics were ordered and given, and the time the sepsis diagnosis was documented.
- The ICU records. If admission to intensive care occurred, the full ICU record — medications, ventilator settings, vasopressor doses, daily progress notes.
- Blood culture and pathogen identification. If a specific pathogen was identified — particularly a multidrug-resistant organism like CRE, ESBL-producing E. coli, Pseudomonas, or vancomycin-resistant Enterococcus — that finding is often decisive for whether the source can be traced to the scope.
- Any letters or notifications from the hospital. Some hospitals send notification letters to patients when a duodenoscope reprocessing issue is identified after the fact. Save the letter and the envelope.
- A timeline you write yourself. When the procedure was, when symptoms started, when you returned, when treatment began. Written down soon after, in your own words.
You do not need to have all of this organized before contacting a lawyer. The lawyer’s job is to assemble it. But preserving the documents you already have — rather than tossing them — matters.
What the Pathogen Identification Means
Two pieces of information from the blood culture result carry particular weight in scope-related cases.
First, the species of bacteria identified. Gram-negative gut and biliary flora — E. coli, Klebsiella pneumoniae, Enterobacter cloacae, Pseudomonas aeruginosa — are the bacteria most commonly involved in scope-related sepsis. These are the bacteria that colonize the duodenum and biliary tree.
Second, the resistance profile. When a blood culture identifies a multidrug-resistant organism — particularly a carbapenem-resistant Enterobacteriaceae (CRE), an extended-spectrum beta-lactamase (ESBL) producer, or a carbapenem-resistant Pseudomonas — the case for a healthcare-acquired source becomes much stronger. CRE in particular has been the signature pathogen in many of the documented Olympus duodenoscope outbreaks. The superbug pathogens guide walks through which organisms have been most frequently traced to scope outbreaks.
If You Survived an ICU Stay After an Endoscopy
A scope-related sepsis case takes the survivor’s entire trajectory into account — not just the original infection. ICU stays often produce long-lasting effects (post-intensive-care syndrome, cognitive symptoms, post-ICU weakness, post-traumatic stress, long-term organ damage). Cases routinely include damages for those downstream effects. Our evidence guide walks through what the case typically needs to prove these elements.
If a Family Member Did Not Survive
When sepsis after an endoscopy is fatal, the family’s wrongful death and survival claims are their own legal questions, with their own filing clocks. Our companion post on wrongful death after a scope-acquired infection walks through who can file, the discovery rule for cases where the family did not know the source of death at the time, and what records help build the case.
If You or a Family Member Has a Possible Case
We represent patients nationwide, regardless of where the procedure happened. A free case review takes about 15 minutes by phone. We evaluate the procedure record, the pathogen identification, the timeline, and the state’s filing deadlines before you decide whether to move forward.
- See if your situation fits the case profile: 3-part qualification test.
- Check filing deadlines: How long do I have to file?
- Read the symptom timeline: Scope infection symptom timeline.
- Read the latest litigation update: Mid-June 2026 litigation status.
Free case review. No Fees Unless We Recover Money for You.
Sources
- Centers for Disease Control and Prevention — "What is sepsis?" and sepsis incidence and mortality data. cdc.gov/sepsis
- Surviving Sepsis Campaign — Hour-1 Bundle and adult sepsis guidelines. sccm.org
- Centers for Medicare & Medicaid Services — SEP-1 (Severe Sepsis and Septic Shock Management Bundle) quality measure. cms.gov
- U.S. Food & Drug Administration — "Duodenoscope Surveillance Sampling and Culturing: Reducing the Risks of Infection." fda.gov
- U.S. FDA — "Infections Associated with Reprocessed Flexible Bronchoscopes and Endoscopes." fda.gov
- CDC Morbidity and Mortality Weekly Report — "Notes from the Field: New Delhi Metallo-β-Lactamase-Producing Escherichia coli Associated with Endoscopic Retrograde Cholangiopancreatography." cdc.gov/mmwr
- American Society for Gastrointestinal Endoscopy (ASGE) — ERCP-related infection guidance. asge.org
- Society for Healthcare Epidemiology of America (SHEA) — Multidrug-resistant organism management resources. shea-online.org
Think You May Have a Case?
The 3-part qualification test takes 2 minutes. If it fits your situation, a free case review is the next step. No Fees Unless We Recover Money for You.